Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (Text with EEA relevance.)

• CELEX: Implementing Regulation (EU) 2019/707
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2020’;

(2)

in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2020’;

(3)

in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2020’;

(4)

in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2020’;

(5)

in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2020’;

(6)

in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2020’;

(7)

in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2020’;

(8)

in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2020’;

(9)

in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2020’;

(10)

in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2020’;

(11)

in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2020’;

(12)

in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2020’;

(13)

in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2020’;

(14)

in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2020’;

(15)

in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2020’;

(16)

in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2020’;

(17)

in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2020’;

(18)

in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2020’;

(19)

in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2020’;

(20)

in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2020’;

(21)

in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2020’;

(22)

in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2020’;

(23)

in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2020’;

(24)

in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2020’;

(25)

in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2020’;

(26)

in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2020’;

(27)

in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2020’;

(28)

in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2020’;

(29)

in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2020’;

(30)

in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2020’;

(31)

in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2020’;

(32)

in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2020’;

(33)

in the sixth column, expiration of approval, of row 192, Diuron, the date is replaced by ‘30 September 2020’;

(34)

in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘31 August 2020’.